Lupus & antiphospholipid syndrome
Association Between Race/Ethnicity and COVID‐19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID‐19 Global Rheumatology Alliance
Authors' conclusion
Black and Hispanic individuals with SLE experienced more severe COVID-19 outcomes, which is consistent with findings in the US general population.
Study context
- Population
- Individuals with systemic lupus erythematosus (SLE) from the US entered into the COVID-19 Global Rheumatology Alliance registry, March 24, 2020 to August 27, 2021473 (90.4%) female
- Participants
- 523 individuals
- Exposure
- Black, Hispanic and other race/ethnicity vs White individuals with SLE
- Outcome
- COVID-19 severity (ordinal: not hospitalized, hospitalized with no oxygenation, hospitalized with any ventilation or oxygenation, death)
Methodological detailsCOVID-19 Global Rheumatology Alliance registry, multivariable ordinal logistic regression
- COVID-19 Global Rheumatology Alliance registry
- Multivariable ordinal logistic regression
Main finding
As reported in the abstract
Odds of more severe COVID-19 outcomes (multivariable model)
Each group vs whiteOdds ratio (95% CI)
Black
2.73(1.36–5.53)
Hispanic
2.76(1.34–5.69)
Observational data: associations, not effects.
Further findings
COVID-19 outcome distribution, all patients
- Not hospitalized
- 358 (74.6%)
- Hospitalized without oxygen
- 40 (8.3%)
- Hospitalized with any oxygenation
- 64 (13.3%)
- Died
- 18 (3.8%)
Original publication
Association Between Race/Ethnicity and COVID‐19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID‐19 Global Rheumatology Alliance. Arthritis Care Res (Hoboken). Published 2 December 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →